Actuality was dense in 2017 for oncology and hematology. The editorial board of the Bulletin du Cancer proposes a selection of key data distinguishing four trends: precision medicine, immunotherapy, focus on early stages and global management of metastatic disease. A summary of results which have been published or presented in congresses is proposed and the impact on daily practices is discussed.
Keywords: Actualité; Early stages; Immunotherapy; Immunothérapie; Maladie métastatique; Metastatic disease; Médecine de précision; Oncology; Precision medicine; Stades précoces.
Copyright © 2017 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.